Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganqing granules for non-alcoholic simple fatty liver disease
CTR20133003Phase 2Completed
- Sponsor
- Tianjin University of Traditional Chinese Medicine
- Start
- Apr 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ganqing granules in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Tianjin University of Traditional Chinese Medicine. Started Apr 2014; status: completed.
02
Drugs
Ganqing granules
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on CTR20133003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20133003.